Bond Labs to Co-Sponsor MMA Event

OMAHA, Neb.--()--Bond Laboratories, Inc. (OTCBB:BNLB) (“Bond Labs”), an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through its wholly owned operating division, NDS Nutrition Products (“NDS”), today announced that the Company will join GNC® as an advertiser and co-sponsor of the Australian Fighting Championship (“AFC”), Australia’s leading Mixed Martial Arts (“MMA”) platform and brand.

“GNC presently has over 1,600 international franchise stores in 56 different countries. We anticipate that our success in Australia will serve as a building block and prototype for aggressive and continued international expansion”

“The decision to partner with GNC to Co-Sponsor the AFC was a natural extension of our recent and highly successful launch into the Australian market. The AFC, which showcases the best Australian and international MMA talent, is an excellent opportunity to build product awareness and entrench NDS as an established premium brand in the region,” stated John Wilson, Bond Labs’ President & CEO. “GNC presently has over 1,600 international franchise stores in 56 different countries. We anticipate that our success in Australia will serve as a building block and prototype for aggressive and continued international expansion,” concluded Mr. Wilson.

About Bond Labs

Bond Laboratories is a manufacturer of innovative nutritional supplements. The Company produces and markets products through its NDS Nutrition division. NDS’ products number over 50 brands of energy, sports and dietary supplements. These products are sold directly through specialty health and nutrition retailers, including top-selling products at GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.

Forward-Looking Statement

Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company’s actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company’s ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Company’s pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company’s filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

Contacts

Surety Financial Group, LLC
Bruce Weinstein
410-833-0078

Recent Stories

RSS feed for Bond Laboratories

Bond Laboratories